Clinical Trial Research Updates

Weekly plain-language updates on clinical trial activity, written for patients and caregivers. TrialsAlert publishes research updates every Friday covering the most notable trials across all monitored conditions.

What are clinical trial research updates?

Clinical trial research updates are weekly summaries of new and updated clinical trials published on ClinicalTrials.gov, the world's largest registry of clinical studies. Each update covers a specific medical specialty or condition, highlighting the most significant trials from the past week. Our AI scores each trial across six dimensions — phase importance, breakthrough potential, patient accessibility, condition prevalence, sponsor credibility, and relevance — then classifies them as breakthrough, notable, or routine. The resulting briefings explain what changed, who is sponsoring the research, what phase it is in, and why it matters for patients, all in plain English without medical jargon. These updates serve patients, caregivers, and support communities who want to stay informed about clinical research without spending hours searching databases themselves.

Recent Updates

Immunology Clinical Trials Update: Week 45, 2026

November 6, 2026 — 5 trials covered | Immunology

A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy This Phase 2 trial is testing a new treatment called PVX108 for children and adolescents who have peanut allergies...

Urology Clinical Trials Update: Week 45, 2026

November 6, 2026 — 5 trials covered | Urology

Effect of Oxybutynin on Opioid Use After Urologic Surgery in Children This study is exploring whether giving children oxybutynin before urologic surgery can help reduce their need for opioid pain medi...

Rare Diseases Clinical Trials Update: Week 45, 2026

November 6, 2026 — 5 trials covered | Rare Diseases

A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice This ongoing study looks at how three different treatments—eteplirsen, golodirsen, and cas...

Skin Conditions & Dermatology Clinical Trials Update: Week 45, 2026

November 6, 2026 — 5 trials covered | Skin Conditions & Dermatology

A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Ext...

Kidney Disease & Nephrology Clinical Trials Update: Week 45, 2026

November 6, 2026 — 5 trials covered | Kidney Disease & Nephrology

Ticagrelor for Inflammation and Cardiovascular Risk in Patients With Chronic Kidney Disease This Phase 2 trial is studying ticagrelor, a pill that may reduce inflammation in adults with chronic kidney...

Autoimmune & Rheumatology Clinical Trials Update: Week 45, 2026

November 6, 2026 — 5 trials covered | Autoimmune & Rheumatology

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients This Phase 3 trial compares two biologic treatments, guselkumab and golimumab, in adults with psoriatic arthritis who have not had good...

Eye Disease & Ophthalmology Clinical Trials Update: Week 45, 2026

November 6, 2026 — 5 trials covered | Eye Disease & Ophthalmology

Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age This Phase 3 trial is testing new digital therapies for children aged 8 to 12 with amblyopia, commonly known as lazy eye. The study c...

Lung & Respiratory Disease Clinical Trials Update: Week 45, 2026

November 6, 2026 — 5 trials covered | Lung & Respiratory Disease

Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites This Phase 4 study from Memorial Sloan Kettering Cancer Center is testing different ways to help smokers quit during lung canc...

Women's Health & Gynecology Clinical Trials Update: Week 45, 2026

November 6, 2026 — 5 trials covered | Women's Health & Gynecology

Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial) This Phase 2 trial is testing whether daily pravastatin can help pregnant women who have preeclampsia or fetal gr...

Pediatrics & Child Health Clinical Trials Update: Week 45, 2026

November 6, 2026 — 5 trials covered | Pediatrics & Child Health

RIC-NEC Randomized Controlled Trial This Phase II trial studied a new treatment called remote ischemic conditioning for newborns with necrotizing enterocolitis (NEC), which is a serious intestinal dis...

Infectious Disease Clinical Trials Update: Week 45, 2026

November 6, 2026 — 5 trials covered | Infectious Disease

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia This Phase 3 trial is exploring several treatments for people hospitalized with community-acquired pneumon...

Blood Disorders & Hematology Clinical Trials Update: Week 45, 2026

November 6, 2026 — 5 trials covered | Blood Disorders & Hematology

A Study to Evaluate Surovatamig Combined With R-CHOP in Participants of 18 to < 80 Years of Age With Previously Untreated Large B-cell Lymphoma With IPI Score 2 to 5 This Phase 3 trial is testing a...

Diabetes & Endocrinology Clinical Trials Update: Week 45, 2026

November 6, 2026 — 5 trials covered | Diabetes & Endocrinology

A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes This Phase 3 trial is testing a new combination drug called EloraTZP for adults who have both obesity or are ov...

Mental Health & Psychiatry Clinical Trials Update: Week 45, 2026

November 6, 2026 — 5 trials covered | Mental Health & Psychiatry

Long-term Maintenance Study of Aripiprazole in the Treatment of Irritability Associated With Autistic Disorder This completed Phase 4 study involved 215 children with irritability related to autism ac...

Orthopedics & Musculoskeletal Clinical Trials Update: Week 45, 2026

November 6, 2026 — 5 trials covered | Orthopedics & Musculoskeletal

A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1) This Phase 3 study is exploring whether the drug berobenatide can help adults...

Heart Disease & Cardiology Clinical Trials Update: Week 45, 2026

November 6, 2026 — 5 trials covered | Heart Disease & Cardiology

A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity This Phase 3 study is exploring the medicine CagriSema ...

Neurology & Brain Disorders Clinical Trials Update: Week 45, 2026

November 6, 2026 — 5 trials covered | Neurology & Brain Disorders

Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease This Phase 2 trial is exploring a new treat...

Immunology Clinical Trials Update: Week 44, 2026

October 30, 2026 — 5 trials covered | Immunology

Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children This Phase 3 follow-up study looks at how well DBV712, an oral treatment for peanut allergy, works ...

Urology Clinical Trials Update: Week 44, 2026

October 30, 2026 — 5 trials covered | Urology

Effect of Intravesical B.C.G and Gemcitabine on Semen Analysis and Testicular Volume in NMIBC This completed study from Egypt looked at how bladder cancer treatments using B.C.G and gemcitabine affect...

Autoimmune & Rheumatology Clinical Trials Update: Week 44, 2026

October 30, 2026 — 5 trials covered | Autoimmune & Rheumatology

Withdrawal Versus Continued TNF Inhibitor Monotherapy Treatment in Children With Inactive Juvenile Idiopathic Arthritis This Phase 4 trial from Oslo University Hospital is exploring whether children a...

Rare Diseases Clinical Trials Update: Week 44, 2026

October 30, 2026 — 5 trials covered | Rare Diseases

Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency This Phase 3 trial is testing an oral medication called pyridoxal 5'-phosphate for people with PNPO deficiency, a rare ge...

Kidney Disease & Nephrology Clinical Trials Update: Week 44, 2026

October 30, 2026 — 5 trials covered | Kidney Disease & Nephrology

Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia This Phase 3 trial is studying whether DDAVP can help prevent dangerous rapid increases in sodium levels in patien...

Eye Disease & Ophthalmology Clinical Trials Update: Week 44, 2026

October 30, 2026 — 5 trials covered | Eye Disease & Ophthalmology

A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME) This Phase 3 trial is testing a new injection called 4D-150 for adults with diabetic macular edema, a c...

Skin Conditions & Dermatology Clinical Trials Update: Week 44, 2026

October 30, 2026 — 5 trials covered | Skin Conditions & Dermatology

Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis This Phase 4 trial led by Maastricht University Medical Center in the Netherlands stu...

Lung & Respiratory Disease Clinical Trials Update: Week 44, 2026

October 30, 2026 — 5 trials covered | Lung & Respiratory Disease

Addiction Potential of Very Low Nicotine Filtered Little Cigars This Phase 4 trial by Ohio State University Comprehensive Cancer Center explores how lowering nicotine in filtered little cigars might c...

Pediatrics & Child Health Clinical Trials Update: Week 44, 2026

October 30, 2026 — 5 trials covered | Pediatrics & Child Health

Effect of Probiotic and Zinc Supplementations on the Clinical Outcome in Pediatric Patients With Ventriculitis This completed Phase 4 trial from Ain Shams University in Egypt studied the use of probio...

Women's Health & Gynecology Clinical Trials Update: Week 44, 2026

October 30, 2026 — 5 trials covered | Women's Health & Gynecology

HB0025-C-0301: A Study to Investigate HB0025 Combined With Chemotherapy as First-Line Treatment for Advanced or Recurrent MMR-proficient Endometrial Cancer This Phase III trial is exploring whether ad...

Diabetes & Endocrinology Clinical Trials Update: Week 44, 2026

October 30, 2026 — 5 trials covered | Diabetes & Endocrinology

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk This Phase 3 trial is testing a once-weekly medication called elorali...

Subscribe to get weekly briefings for your specific condition.